Board Meeting
The next board meeting for Nkarta Inc is on 28 Mar 2025 for the purpose of Nkarta Inc Annual Report for 2024
See details
Nkarta Inc Key Metrics
Select
All financials are in USD Million and price data in USD
VIEW MORE
Not Eligible
Expensive Valuation
Technically Bearish
Check Before You Buy
VIEW FULL CHECKLISTMedium rank
9Positive10Negative
47.4% Pass in checklist
Check P/E Buy Sell Zone
This stock has negative PE
Nkarta Inc Stock Price Analysis
Day Price Range | 2 (LTP) 1.52.3 LowHigh |
Week Price Range | 2 (LTP) 1.32.3 LowHigh |
Month Price Range | 2 (LTP) 1.32.3 LowHigh |
52 Week Price Range | 2 (LTP) 1.311.8 LowHigh |
Nkarta Inc Live Price Chart
Switch to TradingView
Fetching data ...
Revenue forecast
Forecaster is a Premium Feature
You need to upgrade your subscription plan to access this feature
See what you get Nkarta Inc Stock Analysis
Nkarta Inc stock analysis with key metrics, changes, and trends.
Nkarta Inc Metric | VALUE | CHANGE % | TREND | ANALYSIS | |
---|---|---|---|---|---|
Annual Net Profit | $117.5 M | 3.95% | positive |
| |
Price to Earning Ratio | -1.26 | - | negative |
| |
Stock Price | $1.97 | -80.04% | negative |
| |
Quarterly Net profit | $28.34 M | 10.52% | negative |
| |
Debt to Equity Ratio | 0.32 | - | positive |
| |
Return on Equity(ROE) | -36.41 % | -36.41% | negative |
| |
Mutual Fund Holding | 25.59 % | 1.08% | positive |
| |
Institutional Holding | 92.95 % | -2.91% | negative |
|
Loading data..
Nkarta Inc - Company Profile
What does Nkarta Inc do?
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer and autoimmune diseases. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
Nkarta Inc Management structure
All Gross Remunerations are in USD